Immunological Data Discovery Index
Advanced Search
identifier: SDY654
description:
Aging of the world population and a concomitant increase in age-related diseases and disabilities mandates the search for strategies to increase healthspan, the length of time an individual lives healthy and productively. Due to the age-related decline of the immune system, infectious diseases remain among the top 5-10 causes of mortality and morbidity in the elderly, and improving immune function during aging remains an important aspect of healthspan extension. Calorie restriction (CR) and more recently rapamycin (rapa) feeding have both been used to extend lifespan in mice. Preciously few studies have actually investigated the impact of each of these interventions upon in vivo immune defense against relevant microbial challenge in old organisms. We tested how rapa and CR each impacted the immune system in adult and old mice. We report that each intervention differentially altered T-cell development in the thymus, peripheral T-cell maintenance, T-cell function and host survival after West Nile virus infection, inducing distinct but deleterious consequences to the aging immune system. We conclude that neither rapa feeding nor CR, in the current form/administration regimen, may be optimal strategies for extending healthy immune function and, with it, lifespan.
aggregation:
instance of dataset
refinement:
2 - Complete set of descriptive data and results, as ascertained by ImmPort.
availability:
available with registration
primaryPublications: 25424641
isAbout:
Determine the effects of calorie restriction during acute viral challenge
clinical trial:
study category: Immune Response
study type: Intervention Longitudinal
subject species: Mus musculus
biosample type:
subject gender: Male
assay type: ELISA
Flow Cytometry
Q-PCR
name:
Life-prolonging CR and rapa erode immunity
fullName:
Janko Nikolich-Zugich
affiliations:
University of Arizona
roles:
principal investigator
name:
Lifespan-extending caloric restriction or mTOR inhibition impair adaptive immunity of old mice by distinct mechanisms.
size:
10
name:
Immunological basis of age-related vulnerability in biodefense and emerging infections SP2 UAz
output:
FCM, challenge,
studyGroups:
Goldberg_AgingCell_2015_Adult: 4 months old C57BL/6 mice
Goldberg_AgingCell_2015_Old: 16-18 months old C57BL/6 mice
Goldberg_AgingCell_2015_Old_CR: 16-18 months old C57BL/6 mice that have been calorie restricted
Goldberg_AgingCell_2015_Old_Rapa: 16-18 months old C57BL/6 mice that have been treated with rapamycin
description:
Aging of the world population and a concomitant increase in age-related diseases and disabilities mandates the search for strategies to increase healthspan, the length of time an individual lives healthy and productively. Due to the age-related decline of the immune system, infectious diseases remain among the top 5-10 causes of mortality and morbidity in the elderly, and improving immune function during aging remains an important aspect of healthspan extension. Calorie restriction (CR) and more recently rapamycin (rapa) feeding have both been used to extend lifespan in mice. Preciously few studies have actually investigated the impact of each of these interventions upon in vivo immune defense against relevant microbial challenge in old organisms. We tested how rapa and CR each impacted the immune system in adult and old mice. We report that each intervention differentially altered T-cell development in the thymus, peripheral T-cell maintenance, T-cell function and host survival after West Nile virus infection, inducing distinct but deleterious consequences to the aging immune system. We conclude that neither rapa feeding nor CR, in the current form/administration regimen, may be optimal strategies for extending healthy immune function and, with it, lifespan.
identifier:
10.21430/M33E7TCYXT
startDate:
2012-11-01
name:
ImmPort
identifier:
SCR:012804
homePage: http://www.immport.org

Feedback?

If you are having problems using our tools, or if you would just like to send us some feedback, please post your questions on Feedback.